Market revenue in 2024 | USD 591.4 million |
Market revenue in 2030 | USD 825.1 million |
Growth rate | 5.7% (CAGR from 2024 to 2030) |
Largest segment | Defibrillators |
Fastest growing segment | Pacemakers |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pacemakers, Defibrillators, Cardiac Resynchronization Therapy (CRT) |
Key market players worldwide | Stryker Corp, BIOTRONIK, SCHILLER, Medtronic PLC, Abbott Laboratories, Koninklijke Philips NV, ZOLL Medical Corporation, Boston Scientific Corp, LivaNova PLC, Progetti Medical |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cardiac rhythm management devices market will help companies and investors design strategic landscapes.
Defibrillators was the largest segment with a revenue share of 38.52% in 2024. Horizon Databook has segmented the Latin America cardiac rhythm management devices market based on pacemakers, defibrillators, cardiac resynchronization therapy (crt) covering the revenue growth of each sub-segment from 2018 to 2030.
The CRM market in Latin America is expected to witness significant growth over the forecast period, driven by the growing awareness about cardiac arrest & increasing regulatory frameworks to support the availability of AEDs in public & private places. According to the American Heart Association, Inc., more Latin American countries are developing supportive regulatory frameworks to increase the availability of AEDs in high-traffic locations.
Countries such as Colombia, Panama, Chile, Argentina, Puerto Rico, and Uruguay have already implemented laws to regulate the use of AEDs. Growing investments by key companies in the external defibrillator market, such as Nihon Kohden, and supportive regulations are among the key factors expected to contribute to market growth in Latin America over the forecast period.
In 2020, Nihon Kohden reported double-digit growth in international sales, including Latin America and the U.S., due to the increased demand during the COVID-19 pandemic. Sales in Colombia and Mexico, in particular, recorded 200% growth due to a surge in demand for Nihon Kohden’s defibrillators, ventilators, and patient monitors.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America cardiac rhythm management devices market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America cardiac rhythm management devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account